🇺🇸 Buccal midazolam in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Accident — 1 report (10%)
2. Autosomal Chromosome Anomaly — 1 report (10%)
3. Balance Disorder — 1 report (10%)
4. Disturbance In Attention — 1 report (10%)
5. Drug Interaction — 1 report (10%)
6. Fatigue — 1 report (10%)
7. Feeling Abnormal — 1 report (10%)
8. General Physical Health Deterioration — 1 report (10%)
9. Headache — 1 report (10%)
10. Hospitalisation — 1 report (10%)

Source database →

Frequently asked questions

Is Buccal midazolam approved in United States?

Buccal midazolam does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Buccal midazolam in United States?

Hamad Medical Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.